Silmäkeskuksen vastuualue

Medicine & Life Sciences

1. Glaucoma 100%
2. Eye 88%
3. Finland 68%
4. Retinal Pigment Epithelium 64%
5. Population 55%
6. Eye Diseases 54%
7. Ocular Vision 53%
8. Vision Disorders 47%
9. Visual Field Tests 45%
10. Quality of Life 41%
11. tear proteins 40%
12. Body Mass Index 39%
13. Health 37%
14. Pinus sylvestris 36%
15. Proteomics 36%
16. Macular Degeneration 34%
17. Epithelial Cells 33%
18. dorzolamide-timolol combination 33%
19. Pathologic Neovascularization 32%
20. Retinal Diseases 31%
21. trabecular meshwork-induced glucocorticoid response protein 30%
22. Syndecan-4 29%
23. Human Embryonic Stem Cells 29%
24. Diabetic Retinopathy 29%
25. Multifocal Intraocular Lenses 28%
26. Visual Acuity 28%
27. Pseudoxanthoma Elasticum 28%
28. angiotensin I (1-7) 26%
29. Oxygen 26%
30. Intraocular Pressure 25%
31. Ophthalmology 25%
32. Dry Eye Syndromes 25%
33. cadherin 5 25%
34. Elderly 25%
35. Laser In Situ Keratomileusis 23%
36. Amblyopia 23%
37. Hyperoxia 23%
38. Automation 22%
39. Vascular Malformations 22%
40. Intraocular Lens Implantation 22%
41. Proteins 22%
42. Retina 22%
43. Tears 22%
44. Aqueous Humor 22%
45. Sodium Channels 21%
46. Mental Health 21%
47. Pluripotent Stem Cells 21%
48. Stem Cells 21%
49. Facial Paralysis 21%
50. Induced Pluripotent Stem Cells 20%
51. Thinness 20%
52. Registries 20%
53. Phagocytosis 20%
54. Facial Nerve 20%
55. Calcium Channels 19%
56. Erectile Dysfunction 19%
57. Renin-Angiotensin System 19%
58. Incidence 18%
59. Hematopoietic Stem Cells 18%
60. Vascular Endothelial Growth Factor A 17%
61. Lenses 17%
62. Uncertainty 17%
63. Fungi 16%
64. Obesity 16%
65. Morbid Obesity 16%
66. Cost-Benefit Analysis 16%
67. Blood Pressure 15%
68. Cohort Studies 15%
69. Rodentia 15%
70. Mitochondria 15%
71. Cell Differentiation 15%
72. Hypertension 15%
73. Peptides 14%
74. Prospective Studies 14%
75. Epithelium 14%
76. Exfoliation Syndrome 13%
77. Learning 13%
78. Mass Spectrometry 13%
79. Blood Vessels 12%
80. Demography 11%
81. Breast Neoplasms 11%
82. Therapeutics 11%
83. Serum 11%
84. Hypoxia 10%
85. Transplantation 10%
86. Ecosystem 10%
87. Exudates and Transudates 10%
88. Visual Fields 10%
89. Benchmarking 10%
90. Genes 9%
91. Middle Aged 9%
92. Africa South of the Sahara 9%
93. Cross-Sectional Studies 9%
94. Epidermal Growth Factor 9%
95. Income 8%
96. Open Angle Glaucoma 8%
97. Hyperglycemia 8%
98. Osteoarthritis 8%
99. Inflammation 8%
100. Odds Ratio 8%